(Q33567396)

28 July 2017

Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro (English)

1 reference

28 July 2017

hepatocellular carcinoma

1 reference

Juan Jin

1

1 reference

28 July 2017

Yan Chang

2

1 reference

28 July 2017

Wei Wei

3

1 reference

28 July 2017

Yi-fu He

4

1 reference

28 July 2017

Shan-shan Hu

5

1 reference

28 July 2017

Di Wang

6

1 reference

28 July 2017

Yu-jing Wu

7

1 reference

28 July 2017

1 May 2012

1 reference

Acta Pharmacologica Sinica

28 July 2017

1 reference

28 July 2017

33

1 reference

28 July 2017

5

1 reference

28 July 2017

701-709

1 reference

https://scigraph.springernature.com/pub.10.1038/aps.2012.13

28 July 2017

0 references

cites work

Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Molecular targets for the cancer preventive activity of tea polyphenols

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Cyclooxygenase-2 and its role in colorectal cancer development

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Antioxidant Activity of Tea Polyphenols In Vivo: Evidence from Animal Studies

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4010354

Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea.

14 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

(-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

A ride on the ferrous wheel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAPS.2012.13

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22555372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Differential expression of E-prostanoid receptors in human hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22555372

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/APS.2012.13

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference